90‐day oral toxicity study in rats of a protein‐rich powder derived from Xanthobacter sp. SoF1

Xanthobacter sp. SoF1 (SoF1) is an autotrophic hydrogen‐oxidizing bacteria that produces protein‐rich biomass and has potential to be an alternative protein source that is more environmentally sustainable than animal and plant derived proteins. A protein‐rich powder derived from SoF1 was the test ma...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Journal of applied toxicology Ročník 44; číslo 11; s. 1816 - 1830
Hlavní autoři: Choi, Bean, Glávits, Róbert, Murbach, Timothy S., Endres, John R., Hirka, Gábor, Szakonyiné, Ilona Pasics
Médium: Journal Article
Jazyk:angličtina
Vydáno: England Wiley Subscription Services, Inc 01.11.2024
Témata:
Administration, Oral
Animals
Bacterial Proteins - toxicity
Dose-Response Relationship, Drug
Female
hydrogen oxidizing bacteria
Male
microbial protein
No-Observed-Adverse-Effect Level
NOAEL
Organs
Powders
Proteins
Rats
Rats, Wistar
safety
single cell protein
Toxicity
Toxicity testing
Whey protein
Xanthobacter
toxicity
Xanthobacter
safety
NOAEL
microbial protein
single cell protein
hydrogen oxidizing bacteria
ISSN:0260-437X, 1099-1263, 1099-1263
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Xanthobacter sp. SoF1 (SoF1) is an autotrophic hydrogen‐oxidizing bacteria that produces protein‐rich biomass and has potential to be an alternative protein source that is more environmentally sustainable than animal and plant derived proteins. A protein‐rich powder derived from SoF1 was the test material in a 90‐day repeated‐dose oral toxicity study to explore major toxic effects, demonstrate target organs, and provide an estimate of a no‐observed‐adverse‐effect level (NOAEL). Daily doses of 0 (vehicle only), 375, 750, and 1500 mg/kg bw/day of the test material were administered by gavage to 10 Han:WIST rats/sex/group. An additional group was administered 1290 mg/kg bw/day whey protein concentrate as positive control. No treatment‐related adverse effects were observed, and no target organs were determined after 90/91 days of consecutive administration of the test item. A NOAEL of 1500 mg/kg bw/day was determined. A 90‐day repeated‐dose oral toxicity study was conducted to assess the subchronic toxicity of a microbial protein powder derived from Xanthobacter sp. SoF1. Daily doses of 0 (vehicle only), 375, 750, and 1500 mg/kg bw/day of the test material and 1290 mg/kg whey protein concentrate as a positive control were administered by gavage to 10 Han:WIST rats/sex/group. A no‐observed‐adverse‐effect‐level of 1500 mg/kg bw/day was determined.
AbstractList Xanthobacter sp. SoF1 (SoF1) is an autotrophic hydrogen‐oxidizing bacteria that produces protein‐rich biomass and has potential to be an alternative protein source that is more environmentally sustainable than animal and plant derived proteins. A protein‐rich powder derived from SoF1 was the test material in a 90‐day repeated‐dose oral toxicity study to explore major toxic effects, demonstrate target organs, and provide an estimate of a no‐observed‐adverse‐effect level (NOAEL). Daily doses of 0 (vehicle only), 375, 750, and 1500 mg/kg bw/day of the test material were administered by gavage to 10 Han:WIST rats/sex/group. An additional group was administered 1290 mg/kg bw/day whey protein concentrate as positive control. No treatment‐related adverse effects were observed, and no target organs were determined after 90/91 days of consecutive administration of the test item. A NOAEL of 1500 mg/kg bw/day was determined. A 90‐day repeated‐dose oral toxicity study was conducted to assess the subchronic toxicity of a microbial protein powder derived from Xanthobacter sp. SoF1. Daily doses of 0 (vehicle only), 375, 750, and 1500 mg/kg bw/day of the test material and 1290 mg/kg whey protein concentrate as a positive control were administered by gavage to 10 Han:WIST rats/sex/group. A no‐observed‐adverse‐effect‐level of 1500 mg/kg bw/day was determined.
Xanthobacter sp. SoF1 (SoF1) is an autotrophic hydrogen-oxidizing bacteria that produces protein-rich biomass and has potential to be an alternative protein source that is more environmentally sustainable than animal and plant derived proteins. A protein-rich powder derived from SoF1 was the test material in a 90-day repeated-dose oral toxicity study to explore major toxic effects, demonstrate target organs, and provide an estimate of a no-observed-adverse-effect level (NOAEL). Daily doses of 0 (vehicle only), 375, 750, and 1500 mg/kg bw/day of the test material were administered by gavage to 10 Han:WIST rats/sex/group. An additional group was administered 1290 mg/kg bw/day whey protein concentrate as positive control. No treatment-related adverse effects were observed, and no target organs were determined after 90/91 days of consecutive administration of the test item. A NOAEL of 1500 mg/kg bw/day was determined.
Xanthobacter sp. SoF1 (SoF1) is an autotrophic hydrogen-oxidizing bacteria that produces protein-rich biomass and has potential to be an alternative protein source that is more environmentally sustainable than animal and plant derived proteins. A protein-rich powder derived from SoF1 was the test material in a 90-day repeated-dose oral toxicity study to explore major toxic effects, demonstrate target organs, and provide an estimate of a no-observed-adverse-effect level (NOAEL). Daily doses of 0 (vehicle only), 375, 750, and 1500 mg/kg bw/day of the test material were administered by gavage to 10 Han:WIST rats/sex/group. An additional group was administered 1290 mg/kg bw/day whey protein concentrate as positive control. No treatment-related adverse effects were observed, and no target organs were determined after 90/91 days of consecutive administration of the test item. A NOAEL of 1500 mg/kg bw/day was determined.Xanthobacter sp. SoF1 (SoF1) is an autotrophic hydrogen-oxidizing bacteria that produces protein-rich biomass and has potential to be an alternative protein source that is more environmentally sustainable than animal and plant derived proteins. A protein-rich powder derived from SoF1 was the test material in a 90-day repeated-dose oral toxicity study to explore major toxic effects, demonstrate target organs, and provide an estimate of a no-observed-adverse-effect level (NOAEL). Daily doses of 0 (vehicle only), 375, 750, and 1500 mg/kg bw/day of the test material were administered by gavage to 10 Han:WIST rats/sex/group. An additional group was administered 1290 mg/kg bw/day whey protein concentrate as positive control. No treatment-related adverse effects were observed, and no target organs were determined after 90/91 days of consecutive administration of the test item. A NOAEL of 1500 mg/kg bw/day was determined.
Author Szakonyiné, Ilona Pasics
Hirka, Gábor
Murbach, Timothy S.
Choi, Bean
Endres, John R.
Glávits, Róbert
Author_xml – sequence: 1
  givenname: Bean
  orcidid: 0009-0003-9904-0407
  surname: Choi
  fullname: Choi, Bean
  email: bean@aibmr.com
  organization: AIBMR Life Sciences, Inc
– sequence: 2
  givenname: Róbert
  surname: Glávits
  fullname: Glávits, Róbert
  organization: Toxi‐Coop Zrt
– sequence: 3
  givenname: Timothy S.
  orcidid: 0000-0002-7658-858X
  surname: Murbach
  fullname: Murbach, Timothy S.
  organization: AIBMR Life Sciences, Inc
– sequence: 4
  givenname: John R.
  surname: Endres
  fullname: Endres, John R.
  organization: AIBMR Life Sciences, Inc
– sequence: 5
  givenname: Gábor
  surname: Hirka
  fullname: Hirka, Gábor
  organization: Toxi‐Coop Zrt
– sequence: 6
  givenname: Ilona Pasics
  surname: Szakonyiné
  fullname: Szakonyiné, Ilona Pasics
  organization: Toxi‐Coop Zrt
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39098047$$D View this record in MEDLINE/PubMed
BookMark eNp1kc1u1TAQhS3Uit4WJJ4AWWLDJpdxnMT2sqooP6rEoq3UXTR2bNVXufHFdlqy4xF4Rp4ElxaQKroYzWK-OXM055DsTWGyhLxisGYA9bsN5nXTdfwZWTFQqmJ1x_fICuoOqoaLqwNymNIGoMxq-ZwccAVKQiNWRCv4-f3HgAsNEUeawzdvfF5oyvOwUD_RiDnR4CjSXQzZ-qng0Ztrugu3g420lL-xA3UxbOkVTvk6aDS5TNJuTc_DKXtB9h2Oyb586Efk8vT9xcnH6uzLh08nx2eV4Y3iVae1Vg04B61E3Q1CAHcCGbdStcKwxoCsFaA0XDsQQre1tC1qrK1j0CI_Im_vdYvRr7NNud_6ZOw44mTDnHoOUrZtA0IV9M0jdBPmOBV3PWes5p3qFBTq9QM1660d-l30W4xL_-d7_y6aGFKK1v1FGPR3wfQlmP4umIKuH6HlzZh9mHJEP_5vobpfuPWjXZ4U7j8fX_zmfwECMp5i
CitedBy_id crossref_primary_10_1002_jat_4792
Cites_doi 10.3390/foods10050971
10.3390/su13169284
10.1038/221084a0
10.1016/B978-0-12-384947-2.00628-0
10.1177/019262339502300310
10.1002/jat.4621
10.1016/j.copbio.2019.12.026
10.1293/tox.27.1S
10.1016/j.scitotenv.2021.145764
10.1111/1751-7915.12369
10.1007/BF00401402
10.1002/jat.4432
10.1016/s0300-483x(02)00079-3
10.3389/fmicb.2017.02009
10.1177/1091581817746109
ContentType Journal Article
Copyright 2024 AIBMR Life Sciences. published by John Wiley & Sons Ltd.
2024 AIBMR Life Sciences. Journal of Applied Toxicology published by John Wiley & Sons Ltd.
2024. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2024 AIBMR Life Sciences. published by John Wiley & Sons Ltd.
– notice: 2024 AIBMR Life Sciences. Journal of Applied Toxicology published by John Wiley & Sons Ltd.
– notice: 2024. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 24P
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7ST
7TK
7U7
C1K
K9.
SOI
7X8
DOI 10.1002/jat.4663
DatabaseName Wiley Online Library Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Environment Abstracts
Neurosciences Abstracts
Toxicology Abstracts
Environmental Sciences and Pollution Management
ProQuest Health & Medical Complete (Alumni)
Environment Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Toxicology Abstracts
Neurosciences Abstracts
Environment Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList CrossRef
MEDLINE
MEDLINE - Academic

ProQuest Health & Medical Complete (Alumni)
Database_xml – sequence: 1
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
Pharmacy, Therapeutics, & Pharmacology
EISSN 1099-1263
EndPage 1830
ExternalDocumentID 39098047
10_1002_jat_4663
JAT4663
Genre article
Journal Article
GrantInformation_xml – fundername: Solar Foods Oy
  funderid: FI2872116‐8
– fundername: Solar Foods Oy
  grantid: FI2872116-8
GroupedDBID ---
.3N
.GA
.GJ
.Y3
05W
0R~
10A
1L6
1OB
1OC
1ZS
24P
31~
33P
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52S
52T
52U
52W
52X
53G
5GY
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A03
AAESR
AAEVG
AAHHS
AAHQN
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEFU
ABEML
ABIJN
ABJNI
ABPVW
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFNX
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHMBA
AI.
AIAGR
AITYG
AIURR
AIWBW
AJBDE
AJXKR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AUFTA
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMNLL
BMXJE
BNHUX
BROTX
BRXPI
BY8
CS3
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRSTM
EBD
EBS
EDH
EJD
F00
F01
F04
F5P
FEDTE
G-S
G.N
GNP
GODZA
GWYGA
H.T
H.X
HF~
HGLYW
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M6Q
MEWTI
MK4
MRFUL
MRSTM
MSFUL
MSSTM
MXFUL
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
P2P
P2W
P2X
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RIWAO
RJQFR
ROL
RWI
RX1
RYL
SAMSI
SUPJJ
UB1
V8K
VH1
W8V
W99
WBFHL
WBKPD
WH7
WIB
WIH
WIK
WJL
WOHZO
WQJ
WRC
WUP
WWP
WXSBR
WYISQ
XG1
XPP
XV2
YCJ
YHZ
ZXP
ZZTAW
~02
~IA
~KM
~WT
AAMMB
AAYXX
AEFGJ
AEYWJ
AGHNM
AGQPQ
AGXDD
AGYGG
AIDQK
AIDYY
AIQQE
BANNL
CITATION
O8X
CGR
CUY
CVF
ECM
EIF
NPM
7ST
7TK
7U7
C1K
K9.
SOI
7X8
ID FETCH-LOGICAL-c3493-6bbb940ff058ab6d7703f7a13e8957c14c08290a8c3bf077b528e5aba2ef105a3
IEDL.DBID 24P
ISICitedReferencesCount 1
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001283722900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0260-437X
1099-1263
IngestDate Wed Oct 01 14:38:41 EDT 2025
Sat Nov 29 14:31:06 EST 2025
Thu Apr 03 07:03:47 EDT 2025
Tue Nov 18 21:53:01 EST 2025
Sat Nov 29 07:05:29 EST 2025
Wed Jan 22 17:14:11 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords toxicity
Xanthobacter
safety
NOAEL
microbial protein
single cell protein
hydrogen oxidizing bacteria
Language English
License Attribution-NonCommercial-NoDerivs
2024 AIBMR Life Sciences. Journal of Applied Toxicology published by John Wiley & Sons Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3493-6bbb940ff058ab6d7703f7a13e8957c14c08290a8c3bf077b528e5aba2ef105a3
Notes Funding information
The authors disclose that financial support for the research described herein was provided by Solar Foods Oy, Härkälenkki 11 Finland, 01730 Vantaa, Business ID: FI2872116‐8.
Ilona Pasics Szakonyiné is the senior author.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0009-0003-9904-0407
0000-0002-7658-858X
OpenAccessLink https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjat.4663
PMID 39098047
PQID 3112369690
PQPubID 105373
PageCount 15
ParticipantIDs proquest_miscellaneous_3088554079
proquest_journals_3112369690
pubmed_primary_39098047
crossref_primary_10_1002_jat_4663
crossref_citationtrail_10_1002_jat_4663
wiley_primary_10_1002_jat_4663_JAT4663
PublicationCentury 2000
PublicationDate November 2024
2024-11-00
20241101
PublicationDateYYYYMMDD 2024-11-01
PublicationDate_xml – month: 11
  year: 2024
  text: November 2024
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Bognor Regis
PublicationSubtitle JAT
PublicationTitle Journal of applied toxicology
PublicationTitleAlternate J Appl Toxicol
PublicationYear 2024
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2021; 13
2023; 43
1968; 13
2017; 8
2021; 10
2013; 2
1990
2020; 61
2002; 174
1995; 23
2021; 776
2014; 27
1998
2018
2006
2016
2014
2013
2024
2016; 9
2018; 37
1969; 221
e_1_2_9_20_1
Johnson R. (e_1_2_9_9_1) 2013
e_1_2_9_11_1
e_1_2_9_10_1
e_1_2_9_21_1
e_1_2_9_13_1
e_1_2_9_12_1
e_1_2_9_8_1
e_1_2_9_7_1
e_1_2_9_6_1
Srividya A. (e_1_2_9_22_1) 2013; 2
e_1_2_9_5_1
e_1_2_9_4_1
e_1_2_9_3_1
e_1_2_9_2_1
OECD (e_1_2_9_19_1) 2018
Vidal J. (e_1_2_9_24_1) 2013
e_1_2_9_15_1
e_1_2_9_14_1
e_1_2_9_25_1
e_1_2_9_17_1
Vandenberghe J. (e_1_2_9_23_1) 1990
e_1_2_9_16_1
e_1_2_9_18_1
References_xml – volume: 23
  start-page: 338
  issue: 3
  year: 1995
  end-page: 348
  article-title: Incidence of nonneoplastic lesions in historical control male and female Fischer‐344 rats from 90‐day toxicity studies
  publication-title: Toxicologic Pathology
– volume: 61
  start-page: 189
  year: 2020
  end-page: 197
  article-title: Recent advances in single cell protein use as a feed ingredient in aquaculture
  publication-title: Current Opinion in Biotechnology
– year: 2024
  article-title: In vitro genotoxicological evaluation of protein‐rich powder derived from Xanthobacter sp. SoF1
  publication-title: Journal of Applied Toxicology
– start-page: 717
  year: 2013
  end-page: 830
– volume: 13
  issue: 16
  year: 2021
  article-title: Single cell protein: A potential substitute in human and animal nutrition
  publication-title: Sustainability
– volume: 776
  year: 2021
  article-title: An attributional life cycle assessment of microbial protein production: A case study on using hydrogen‐oxidizing bacteria
  publication-title: Science of the Total Environment
– volume: 10
  issue: 5
  year: 2021
  article-title: Microbes: Food for the future
  publication-title: Food
– volume: 174
  start-page: 183
  issue: 3
  year: 2002
  end-page: 200
  article-title: Immunotoxicity of nucleic acid reduced BioProtein‐‐A bacterial derived single cell protein‐‐in Wistar rats
  publication-title: Toxicology
– volume: 37
  start-page: 53
  issue: 1
  year: 2018
  end-page: 62
  article-title: A toxicological evaluation of , a green algae
  publication-title: International Journal of Toxicology
– start-page: 209
  year: 2013
  end-page: 254
– start-page: 790
  year: 2016
  end-page: 794
– volume: 221
  start-page: 84
  issue: 5175
  year: 1969
  end-page: 85
  article-title: Human intolerance to bacteria as food
  publication-title: Nature
– year: 2006
– volume: 8
  year: 2017
  article-title: Single cell protein‐state‐of‐the‐art, industrial landscape and patents 2001‐2016
  publication-title: Frontiers in Microbiology
– volume: 13
  start-page: 222
  issue: 3
  year: 1968
  end-page: 257
  article-title: Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse
  publication-title: Psychopharmacologia
– volume: 9
  start-page: 568
  issue: 5
  year: 2016
  end-page: 575
  article-title: Microbial protein: Future sustainable food supply route with low environmental footprint
  publication-title: Microbial Biotechnology
– volume: 43
  start-page: 887
  year: 2023
  end-page: 912
  article-title: Toxicological evaluation of protein powder derived from
  publication-title: Journal of Applied Toxicology
– year: 2018
– year: 1990
– year: 2014
– volume: 2
  start-page: 472
  issue: 4
  year: 2013
  end-page: 485
  article-title: Single cell protein‐a review
  publication-title: IJPRS
– volume: 27
  start-page: 1S
  issue: 3+4_Suppl
  year: 2014
  end-page: 107S
  article-title: Nonproliferative and proliferative lesions of the rat and mouse female reproductive system
  publication-title: Journal of Toxicologic Pathology
– year: 1998
– ident: e_1_2_9_3_1
  doi: 10.3390/foods10050971
– ident: e_1_2_9_2_1
  doi: 10.3390/su13169284
– ident: e_1_2_9_25_1
  doi: 10.1038/221084a0
– ident: e_1_2_9_16_1
  doi: 10.1016/B978-0-12-384947-2.00628-0
– ident: e_1_2_9_5_1
  doi: 10.1177/019262339502300310
– ident: e_1_2_9_6_1
– ident: e_1_2_9_11_1
  doi: 10.1002/jat.4621
– ident: e_1_2_9_10_1
  doi: 10.1016/j.copbio.2019.12.026
– ident: e_1_2_9_17_1
– ident: e_1_2_9_20_1
– ident: e_1_2_9_4_1
  doi: 10.1293/tox.27.1S
– ident: e_1_2_9_8_1
  doi: 10.1016/j.scitotenv.2021.145764
– start-page: 209
  volume-title: Toxicologic pathology. Nonclinical safety assessment
  year: 2013
  ident: e_1_2_9_9_1
– volume-title: Addendum 3.2
  year: 1990
  ident: e_1_2_9_23_1
– ident: e_1_2_9_12_1
  doi: 10.1111/1751-7915.12369
– volume: 2
  start-page: 472
  issue: 4
  year: 2013
  ident: e_1_2_9_22_1
  article-title: Single cell protein‐a review
  publication-title: IJPRS
– ident: e_1_2_9_18_1
– start-page: 717
  volume-title: Toxicologic pathology. Nonclinical safety assessment
  year: 2013
  ident: e_1_2_9_24_1
– volume-title: Test no. 408: Repeated dose 90‐day oral toxicity study in rodents, OECD guidelines for the testing of chemicals, section 4
  year: 2018
  ident: e_1_2_9_19_1
– ident: e_1_2_9_7_1
  doi: 10.1007/BF00401402
– ident: e_1_2_9_13_1
  doi: 10.1002/jat.4432
– ident: e_1_2_9_14_1
  doi: 10.1016/s0300-483x(02)00079-3
– ident: e_1_2_9_21_1
  doi: 10.3389/fmicb.2017.02009
– ident: e_1_2_9_15_1
  doi: 10.1177/1091581817746109
SSID ssj0009928
Score 2.4066393
Snippet Xanthobacter sp. SoF1 (SoF1) is an autotrophic hydrogen‐oxidizing bacteria that produces protein‐rich biomass and has potential to be an alternative protein...
Xanthobacter sp. SoF1 (SoF1) is an autotrophic hydrogen-oxidizing bacteria that produces protein-rich biomass and has potential to be an alternative protein...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1816
SubjectTerms Administration, Oral
Animals
Bacterial Proteins - toxicity
Dose-Response Relationship, Drug
Female
hydrogen oxidizing bacteria
Male
microbial protein
No-Observed-Adverse-Effect Level
NOAEL
Organs
Powders
Proteins
Rats
Rats, Wistar
safety
single cell protein
Toxicity
Toxicity testing
Whey protein
Xanthobacter
Title 90‐day oral toxicity study in rats of a protein‐rich powder derived from Xanthobacter sp. SoF1
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjat.4663
https://www.ncbi.nlm.nih.gov/pubmed/39098047
https://www.proquest.com/docview/3112369690
https://www.proquest.com/docview/3088554079
Volume 44
WOSCitedRecordID wos001283722900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVWIB
  databaseName: Wiley Online Library - Journals
  customDbUrl:
  eissn: 1099-1263
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0009928
  issn: 0260-437X
  databaseCode: DRFUL
  dateStart: 19960101
  isFulltext: true
  titleUrlDefault: https://onlinelibrary.wiley.com
  providerName: Wiley-Blackwell
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpZ1Lb9QwEIAtaDkgIR7l0YVSDRJaLk1r52X7iIAVh6paQSvlFo0dRyxCyWqzLeyNn8Bv5JcwdrK7qgAJiUOSQyaxFc8rTuYzYy95XfPY5SpCij6-JKeKMDFpZI3IdSydRgwQ11N5dqaKQk-Hvyp9LUzPh9hMuHnLCP7aGzia7mQLDf2My-OU4uVNtitEovyyDXE63QJ3dVhX1SOzqAuyWINneXyyvvJ6KPotv7yeroZ4M7n3Pz29z-4OWSa87tXiAbvhmj02nvaY6tURnG-rrrojGMN0C7Be7bE7_Vwe9CVKD5nR_Of3HxWuwJfzw7L9NrOUvENA08KsAdKiDtoaEAL2YdaQOPnXTzBvv1ZuAbSRU63A17JAgZ5XYAIlGrr5MXxsJ-IRu5i8O3_zPhrWZohskuokyo0xOvUjnSk0eSXJc9QSReKUzqQVqfVFuxyVTUzNpTRZrFyGBmNXU0qHyWO207SN22fguECbYlUjvRpajcZD9WplZZZbYZQYsVfrYSrtAC7362d8KXvkclzSAy79Ax6xFxvJeQ_r-IPMwXqky8FcuzIRHkKjc83pFpvTZGj-6wk2rr0kGfLHmccV6hF70mvIppFEc614KkdsHBThr62X5HT98em_Cj5jt2NKo_rqxwO2s1xcuufslr1azrrFYVB52stCHbLdtx8mF6e_AHN8B-Y
linkProvider Wiley-Blackwell
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpZ3fi9NAEMeH8xQUxB_nqT1PHUHqy-Vu83Oz-CRiObGWghX6FmY3G6xIUpqe2jf_hPsb7y-52aRpOVQQfAh5yCRZdmdnJhu-nwV4KYpCBDZJPeLs4yQ5uUehjjyj_UQF0iqiBuI6lKNROp2q8Q687rQwLR9is-DmZkYTr90EdwvSJ1tq6FdaHkecMK_B9YiTjHPyIBpvibuq2VjVMbO4DXLakWdFcNLdeTUX_VZgXq1Xm4QzuPtfTb0Hd9Z1Jr5pHeM-7NhyD_rjFlS9OsLJVndVH2Efx1uE9WoPbrerediKlB6AVuLi13lOK3SCflxWP2eGy3ds4LQ4K5H9qMaqQMIG_DAr2Zwj7BecVz9yu0A-OKzm6NQsOCVHLNANJxrr-TF-qgb-PnwevJu8PfXWuzN4JoxU6CVaaxW5sY5T0kkuOXYUkvzQpiqWxo-Mk-0KSk2oCyGljoPUxqQpsAUXdRQ-hN2yKu1jQCt8MhHlBfHHoVGkHVavSI2ME-Pr1O_Bq26cMrNGl7sdNL5lLXQ5yLiDM9fBPXixsZy3uI4_2Bx2Q52tJ2ydhb7D0KhECX7E5jJPNff_hEpbnbENR-TYAQtVDx61LrJ5SaiESkUke9BvPOGvb8847Lrzwb8aPoebp5OPw2z4fvThCdwKuKhqtZCHsLtcnNmncMN8X87qxbPG_y8BqIcJSQ
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpZ1bi9NAFIAPa1dEEC_rrbrqEaS-bHYn15nBJ3ENiqUU3YW-hTOTCXZZktJ01b75E_yN_hJncmlZVBB8CHnISTLMnFsmnO8AvGBFwQKTCI9s9HElOblHoYo8rfxEBtxIogbiOuaTiZjN5HQHXvW1MC0fYrPh5iyj8dfOwM0iL4621NAzWh1GNmBegd3I9ZAZwO7xx_R0vGXuyqa1qqNm2VHwWc-eZcFRf-_laPRbink5Y21CTnrrvwZ7G252mSa-blXjDuyYcg9G0xZVvT7Ak23lVX2AI5xuIdbrPbjR7udhW6Z0F5RkP7__yGmNrqQfV9W3ubYJPDZ4WpyXaDWpxqpAwgb9MC-tuPWxn3FRfc3NEu1hHWuOrp4FZ-SYBaohRWO9OMRPVerfg9P07cmbd17Xn8HTYSRDL1FKycitdixIJTm33qPg5IdGyJhrP9KucJeR0KEqGOcqDoSJSVFgCpvWUXgfBmVVmoeAhvmkI8oLsp-HWpJyYL1CaB4n2lfCH8LLfp0y3cHLXQ-N86zFLgeZneDMTfAQnm8kFy2w4w8y-_1SZ53J1lnoOxCNTCSzj9hctsbm_qBQaaoLK2N9cuyQhXIID1oV2bwklEwKFvEhjBpN-OvbM-t43fnRvwo-g2vT4zQbv598eAzXA5tVtcWQ-zBYLS_ME7iqv6zm9fJpZwC_APdnCl8
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=90%E2%80%90day+oral+toxicity+study+in+rats+of+a+protein%E2%80%90rich+powder+derived+from+Xanthobacter+sp.+SoF1&rft.jtitle=Journal+of+applied+toxicology&rft.au=Bean%2C+Choi&rft.au=Gl%C3%A1vits%2C+R%C3%B3bert&rft.au=Murbach%2C+Timothy+S&rft.au=Endres%2C+John+R&rft.date=2024-11-01&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=0260-437X&rft.eissn=1099-1263&rft.volume=44&rft.issue=11&rft.spage=1816&rft.epage=1830&rft_id=info:doi/10.1002%2Fjat.4663&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0260-437X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0260-437X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0260-437X&client=summon